- Home
- MNPR vs MTRX Comparison
MNPR vs MTRX Comparison
Compare MNPR & MTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- MTRX
- Stock Information
- Founded
- MNPR 2014
- MTRX 1984
- Country
- MNPR United States
- MTRX United States
- Employees
- MNPR N/A
- MTRX N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- MTRX Engineering & Construction
- Sector
- MNPR Health Care
- MTRX Consumer Discretionary
- Exchange
- MNPR Nasdaq
- MTRX Nasdaq
- Market Cap
- MNPR 390.5M
- MTRX 405.6M
- IPO Year
- MNPR 2019
- MTRX 1990
- Fundamental
- Price
- MNPR $99.37
- MTRX $12.38
- Analyst Decision
- MNPR Strong Buy
- MTRX Strong Buy
- Analyst Count
- MNPR 12
- MTRX 1
- Target Price
- MNPR $89.82
- MTRX $17.00
- AVG Volume (30 Days)
- MNPR 78.9K
- MTRX 369.8K
- Earning Date
- MNPR 11-07-2025
- MTRX 11-05-2025
- Dividend Yield
- MNPR N/A
- MTRX N/A
- EPS Growth
- MNPR N/A
- MTRX N/A
- EPS
- MNPR N/A
- MTRX N/A
- Revenue
- MNPR N/A
- MTRX $769,286,000.00
- Revenue This Year
- MNPR N/A
- MTRX $18.36
- Revenue Next Year
- MNPR N/A
- MTRX $8.56
- P/E Ratio
- MNPR N/A
- MTRX N/A
- Revenue Growth
- MNPR N/A
- MTRX 5.64
- 52 Week Low
- MNPR $4.50
- MTRX $9.33
- 52 Week High
- MNPR $105.00
- MTRX $16.11
- Technical
- Relative Strength Index (RSI)
- MNPR 88.79
- MTRX 37.50
- Support Level
- MNPR $72.41
- MTRX $12.63
- Resistance Level
- MNPR $105.00
- MTRX $13.01
- Average True Range (ATR)
- MNPR 7.21
- MTRX 0.43
- MACD
- MNPR 2.86
- MTRX 0.02
- Stochastic Oscillator
- MNPR 89.52
- MTRX 4.79
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About MTRX Matrix Service Company
Matrix Service Co is an engineering and construction provider for large industrial projects, primarily in the oil and gas, power, petrochemical, industrial, mining, and minerals markets. It offers engineering, fabrication, construction, and maintenance services, operating across three segments namely Utility and Power Infrastructure; Process and Industrial Facilities; and Storage and Terminal Solutions.